bioRxiv Bioengineering Profile
bioRxiv Bioengineering

@bioRxiv_bioE

Followers
203
Following
1
Media
0
Statuses
6K

Bioengineering preprints | not affiliated with bioRxiv | maintained by @MichaelRetchin

Joined April 2021
Don't wanna be here? Send us removal request.
@bioRxiv_bioE
bioRxiv Bioengineering
1 day
Engineering circular guide RNA and CRISPR-Cas13d-encoding mRNA for the RNA editing of Adar1 in triple-negative breast cancer immunotherapy . #biorxiv_bioE.
Tweet card summary image
biorxiv.org
Clustered regularly interspaced short palindromic repeat Cas endonuclease (CRISPR-Cas) systems, such as RNA-editing CRISPR-Cas13d, are poised to advance the gene therapy of various diseases. However,...
0
0
0
@bioRxiv_bioE
bioRxiv Bioengineering
3 days
Multifunctional Injectable GelMA Hydrogels with MSN-Mediated Spatiotemporal Icariin Release for Enhanced Osseointegration in Bone Defects . #biorxiv_bioE.
Tweet card summary image
biorxiv.org
The repair of bone defects is faced with the dual challenges of limited autograft donors and single function of artificial materials. The development of new materials with mechanical adaptability,...
0
0
0
@bioRxiv_bioE
bioRxiv Bioengineering
5 days
Enabling Organ- and Injury-Specific Nanocarrier Targeting via Surface-Functionalized PEG-b-PPS Micelles for Acute Kidney Injury . #biorxiv_bioE.
Tweet card summary image
biorxiv.org
While nanomedicine holds great promise for kidney disease, targeted delivery remains a major challenge. Most nanocarriers rely on passive accumulation or epithelial-specific ligands, limiting their...
0
0
0
@bioRxiv_bioE
bioRxiv Bioengineering
5 days
Enabling supratheoretical isopropanol yields from carbon-negative glucose fermentations with Clostridium acetobutylicum-Clostridium ljungdahlii cocultures . #biorxiv_bioE.
Tweet card summary image
biorxiv.org
Synthetic microbial cocultures, which combine the unique capabilities of multiple microbes into one process, have significant potential for sustainable production of fuels and chemicals. Most studies...
0
0
0